| | | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
|---|
|
| mars 2002 - 35 Spécialités |
|
| | | IPro | IPat | Sp | Ritalin LA 20 mg | 30 Gélule(s) | 32.00 | 50.85 | 10% | | | Novartis Pharma
Schweiz AG | A+ / LS / SO | FB | | G |  |
| | | IPro | IPat | Sp | Ritalin LA 30 mg | 30 Gélule(s) | 41.57 | 61.20 | 10% | | | Novartis Pharma
Schweiz AG | A+ / LS / SO | FB | | G | |
| | | IPro | IPat | Sp | Ritalin LA 20 mg | 100 Gélule(s) | 90.66 | 114.05 | 10% | | | Novartis Pharma
Schweiz AG | A+ / LS / SO | FB | | G | |
| | | IPro | IPat | Sp | Ritalin LA 30 mg | 100 Gélule(s) | 117.77 | 143.25 | 10% | | | Novartis Pharma
Schweiz AG | A+ / LS / SO | FB | | G | |
| | | IPro | IPat | | Effigel | 60 g | 2.03 | 4.20 | 10% | | gel: Diclofenacum Epolaminum 12.92 mg | IBSA Institut
Biochimique SA | D / LS / SO | FB | | G | |
| | | IPro | IPat | | Daivobet | 30 g | 21.14 | 39.15 | 10% | | Onguent: 2 Principes actifs | LEO Pharmaceutical
Products Sarath Ltd. | B / LS / SO | FB | | G | |
| | | IPro | IPat | | Daivobet | 60 g | 37.19 | 56.45 | 10% | | Onguent: 2 Principes actifs | LEO Pharmaceutical
Products Sarath Ltd. | B / LS / SO | FB | | G | |
| | | IPro | IPat | Sp | Ritalin LA 40 mg | 30 Gélule(s) | 48.00 | 68.10 | 10% | | Capsules: Methylphenidati Hydrochloridum 40 mg | Novartis Pharma
Schweiz AG | A+ / LS / SO | FB | | G | |
| | | IPro | IPat | Sp | Ritalin LA 40 mg | 100 Gélule(s) | 135.99 | 162.85 | 10% | | Capsules: Methylphenidati Hydrochloridum 40 mg | Novartis Pharma
Schweiz AG | A+ / LS / SO | FB | | G | |
| | | IPro | IPat | | Cortinasal 50 | 10 ml | 11.56 | 29.00 | 10% | | Spray nasale: Budesonidum 50 µg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Cortinasal 100 | 10 ml | 21.63 | 39.95 | 10% | | Spray nasale: Budesonidum 100 µg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Atrovent N | 200 inhalation(s) | 9.52 | 26.75 | 10% | | Nébuliseur-doseur: Ipratropii Bromidum 21 µg | Boehringer Ingelheim
(Schweiz) GmbH | B / LS | FB | | G | |
| L | | IPro | IPat | | Caverject DC 10 | 2 seringue(s) | 16.39 | 34.25 | 10% | | Préparation injectable: Alprostadilum 10 µg | Pfizer AG | ● A / LS | FB | | G | |
| L | | IPro | IPat | | Caverject DC 20 | 2 seringue(s) | 27.78 | 46.65 | 10% | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze: Alprostadilum 20 µg | Pfizer AG | ● A / LS | FB | | G | |
| | | IPro | IPat | | Fluomizin ‐ P | 6 Comprimé(s) | 9.24 | 26.45 | 10% | | Comprimés vaginaux: Dequalinii Chloridum 10 mg | Medinova AG | B / LS | FB | | G | |
| | | IPro | IPat | Sp | Ritalin LA 10 mg | 30 Gélule(s) | DDP | DDP | N.O. | | | Novartis Pharma
Schweiz AG | A+ | FB | | G | |
| | | IPro | IPat | Sp | Ritalin LA 10 mg | 100 Gélule(s) | DDP | DDP | N.O. | | | Novartis Pharma
Schweiz AG | A+ | FB | | G | |
| | | IPro | IPat | | Nicotinell Mint 1 mg | 36 Comprimé(s) | DDP | DDP | N.O. | | Comprimés à succer: Nicotinum 1 mg | Haleon Schweiz AG | D / LPPA | FB | | G | |
| | | IPro | IPat | | Nicotinell Mint 1 mg | 96 Comprimé(s) | DDP | DDP | N.O. | | Comprimés à succer: Nicotinum 1 mg | Haleon Schweiz AG | D / LPPA | FB | | G | |
| | | IPro | IPat | | Nicotinell Mint 1 mg | 204 Comprimé(s) | DDP | DDP | N.O. | | Comprimés à succer: Nicotinum 1 mg | Haleon Schweiz AG | D / LPPA | FB | | G | |
| | | IPro | IPat | | Nicotinell Mint 2 mg | 36 Comprimé(s) | DDP | DDP | N.O. | | Comprimés à succer: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPA | FB | | G | |
| | | IPro | IPat | | Nicotinell Mint 2 mg | 96 Comprimé(s) | DDP | DDP | N.O. | | Comprimés à succer: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPA | FB | | G | |
| | | IPro | IPat | | Nicotinell Mint 2 mg | 204 Comprimé(s) | DDP | DDP | N.O. | | Comprimés à succer: Nicotinum 2 mg | Haleon Schweiz AG | D | FB | | G | |
| | | IPro | IPat | | Effigel | 100 g | DDP | DDP | N.O. | | gel: Diclofenacum Epolaminum 12.92 mg | IBSA Institut
Biochimique SA | D | FB | | G | |
| | | | IPat | H | Sanukehl Pseu D6 | 10 ml | DDP | DDP | N.O. | | Gouttes: Pseudomonas Aeruginosa Extractum (Lyophil., Steril.) Aquos D6 Dilutio | ebi-pharm ag | B | FB | | G | |
| | | IPro | IPat | | Uprima 2 mg | 4 Comprimé(s) | DDP | DDP | N.O. | | Comprimés sublinguaux: 2 Principes actifs | Abbott AG | B | FB | | G | |
| | | IPro | IPat | | Uprima 2 mg | 12 Comprimé(s) | DDP | DDP | N.O. | | Comprimés sublinguaux: 2 Principes actifs | Abbott AG | B | FB | | G | |
| | | IPro | IPat | | Uprima 3 mg | 4 Comprimé(s) | DDP | DDP | N.O. | | Comprimés sublinguaux: 2 Principes actifs | Abbott AG | B | FB | | G | |
| | | IPro | IPat | | Uprima 3 mg | 12 Comprimé(s) | DDP | DDP | N.O. | | Comprimés sublinguaux: 2 Principes actifs | Abbott AG | B | FB | | G | |
| | | | | | Nicotimed | 7 pansement(s) | DDP | DDP | N.O. | | Système Transdermique: Nicotinum 17.5 mg | NOVARTIS CONSUMER
HEALTH SCHWEIZ AG | C | FB | | G | |
| | | | | | Nicotimed | 21 pansement(s) | DDP | DDP | N.O. | | Système Transdermique: Nicotinum 17.5 mg | NOVARTIS CONSUMER
HEALTH SCHWEIZ AG | C | FB | | G | |
| | | | | | Nicotimed | 7 pansement(s) | DDP | DDP | N.O. | | Système Transdermique: Nicotinum 35 mg | NOVARTIS CONSUMER
HEALTH SCHWEIZ AG | C | FB | | G | |
| | | | | | Nicotimed | 21 pansement(s) | DDP | DDP | N.O. | | Système Transdermique: Nicotinum 35 mg | NOVARTIS CONSUMER
HEALTH SCHWEIZ AG | C | FB | | G | |
| | | | | | Nicotimed | 7 pansement(s) | DDP | DDP | N.O. | | Système Transdermique: Nicotinum 52.5 mg | NOVARTIS CONSUMER
HEALTH SCHWEIZ AG | C | FB | | G | |
| | | | | | Nicotimed | 21 pansement(s) | DDP | DDP | N.O. | | Système Transdermique: Nicotinum 52.5 mg | NOVARTIS CONSUMER
HEALTH SCHWEIZ AG | C | FB | | G | |
